{"response": {"status": "ok", "userTier": "developer", "total": 1, "content": {"id": "technology/blog/2008/mar/11/phormmystifiedbyfallinsha", "type": "article", "sectionId": "technology", "sectionName": "Technology", "webPublicationDate": "2008-03-11T23:11:22Z", "webTitle": "Phorm mystified by fall in share price; we interview its chief", "webUrl": "https://www.theguardian.com/technology/blog/2008/mar/11/phormmystifiedbyfallinsha", "apiUrl": "https://content.guardianapis.com/technology/blog/2008/mar/11/phormmystifiedbyfallinsha", "fields": {"headline": "Phorm mystified by fall in share price; we interview its chief", "bodyText": "Phorm, the company that has signed with BT, TalkTalk and Virgin Media to provide its \"Webwise\" service, felt moved to put out a statement on Tuesday saying it knew of no reason why its share price had fallen by 30% or so on the day. We don't either. But meanwhile, we have an extended version of the interview I did last Friday with Kent Ertegrul, chief executive of the company, in which I put many of the questions you had raised on the blog (apart from those which weren't questions or had been answered...). Let us know what questions you think remain. (It was described as \"robust\" by some in the studio.) It's 30 minutes - there were lots of questions. Link here. Or listen directly - Launch the audio player"}, "isHosted": false, "pillarId": "pillar/news", "pillarName": "News"}}}